These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8259024)

  • 1. [Hyperandrogenism or insulin resistance. What is the cause and effect in diabetes among women?].
    Holmäng A; Björntorp P
    Lakartidningen; 1993 Dec; 90(48):4313-5. PubMed ID: 8259024
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of ovulation in infertile women with hyperandrogenism and insulin resistance.
    Barbieri RL
    Am J Obstet Gynecol; 2000 Dec; 183(6):1412-8. PubMed ID: 11120504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.
    Legro RS; Castracane VD; Kauffman RP
    Obstet Gynecol Surv; 2004 Feb; 59(2):141-54. PubMed ID: 14752302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?
    Corbould A
    Diabetes Metab Res Rev; 2008 Oct; 24(7):520-32. PubMed ID: 18615851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin receptors and diabetes mellitus (review of the literature)].
    Germaniuk IaL
    Vrach Delo; 1982 Jun; (6):9-13. PubMed ID: 7051562
    [No Abstract]   [Full Text] [Related]  

  • 6. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin down-regulates the inducible nitric oxide synthase pathway: nitric oxide as cause and effect of diabetes?
    Stevens RB; Sutherland DE; Ansite JD; Saxena M; Rossini TJ; Levay-Young BK; Hering BJ; Mills CD
    J Immunol; 1997 Dec; 159(11):5329-35. PubMed ID: 9548472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic hyperandrogenism and/or administered central nervous system insulin on ovarian manifestation and gonadotropin and steroid secretion.
    Allon MA; Leach RE; Dunbar J; Diamond MP
    Fertil Steril; 2005 Apr; 83 Suppl 1():1319-26. PubMed ID: 15831308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestational diabetes mellitus and subsequent development of overt diabetes mellitus.
    Damm P
    Dan Med Bull; 1998 Nov; 45(5):495-509. PubMed ID: 9850811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome and type 2 diabetes mellitus.
    De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
    Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insulin tolerance test. A useful test to determine insulin resistance in obese hyperandrogenic women].
    Sin T; Castillo T; Muñoz S; Candia M; López G; Calvillán M
    Rev Med Chil; 1996 Aug; 124(8):931-7. PubMed ID: 9196992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and self-rated symptoms of depression in Swedish women with risk factors for diabetes: the Women's Health in the Lund Area study.
    Roos C; Lidfeldt J; Agardh CD; Nyberg P; Nerbrand C; Samsioe G; Westrin A
    Metabolism; 2007 Jun; 56(6):825-9. PubMed ID: 17512316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
    Bitar MS; Al-Saleh E; Al-Mulla F
    Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of insulin sensitizers in polycystic ovarian syndrome.
    Baillargeon JP
    Curr Opin Investig Drugs; 2005 Oct; 6(10):1012-22. PubMed ID: 16259222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
    Stefanović V; Antić S
    Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HAIR-AN syndrome (HyperAndrogenism, Insulin Resistance, Acanthosis Nigricans) in an adolescent with Cohen's syndrome].
    Ingletto D; Ruggiero L; De Sanctis V
    Minerva Pediatr; 2001 Oct; 53(5):493-4. PubMed ID: 11668286
    [No Abstract]   [Full Text] [Related]  

  • 18. [Androgen excess in women and the metabolic syndrome (syndrome X)].
    Cabrijan T; Lipovac M; Misjak M
    Lijec Vjesn; 1996 Mar; 118 Suppl 1():24-7. PubMed ID: 8759404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HAIR-AN syndrome: a multisystem challenge.
    Elmer KB; George RM
    Am Fam Physician; 2001 Jun; 63(12):2385-90. PubMed ID: 11430453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of dicholine blockage of H-cholinreactive systems on the reactivity to insulin in insulin-resistent forms of experimental diabetes].
    Drzhevetskaia IA
    Patol Fiziol Eksp Ter; 1968; 12(2):23-5. PubMed ID: 5264471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.